Immune Checkpoint Inhibitors and Radiotherapy in Relapsed/Refractory Hodgkin Lymphoma

Clinical trial NCT04419441 · UNKNOWN

Trial details

NCT number: NCT04419441
Sponsor: Ospedale Maggiore Di Trieste
Status: UNKNOWN
Study type: OBSERVATIONAL

Hodgkin Lymphoma Immune Checkpoint Inhibitor Radiotherapy

Start date: 2020-06-24
Primary completion: 2020-09-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.